Liesl Oldstone, PhD, MBA, R Ph
About Liesl Oldstone, PhD, MBA, R Ph
Liesl Oldstone, PhD, MBA, R Ph, serves as the Vice President of Health Economics and Market Access at AppliedVR and holds an adjunct professor position at UC San Diego's Rady School of Business. With extensive experience in healthcare economics and market access, she has held leadership roles at several prominent companies, including Eli Lilly, Bristol-Myers Squibb, and ResMed.
Work at AppliedVR
Liesl Oldstone serves as the Vice President of Health Economics and Market Access at AppliedVR, a position she has held since 2021. In this role, she focuses on strategies to enhance market access for digital health solutions. Her expertise in health economics is instrumental in navigating the complexities of reimbursement and market entry for innovative healthcare products.
Education and Expertise
Liesl Oldstone holds a Doctor of Philosophy (PhD) in Pharmaceutical and Outcomes Sciences from the University of South Carolina College of Pharmacy, which she completed from 1997 to 2000. She also earned a Master of Business Administration (MBA) in Marketing and Management from Georgia State University from 1990 to 1994. Additionally, she achieved a Certificate in Digital Transformation from the University of California, Berkeley, from 2019 to 2020. Her educational background supports her extensive experience in health economics and market access.
Background
Liesl Oldstone has a diverse professional background in healthcare and market access. She began her career in pharmacy, earning a Bachelor of Science in Pharmacy from Purdue University from 1984 to 1989. Over the years, she has held significant positions at various organizations, including Eli Lilly and Company, Bristol-Myers Squibb, and ResMed, where she developed and led initiatives in health services and market access.
Achievements
Throughout her career, Liesl Oldstone has been involved in several impactful projects. She initiated a reimbursement proposal for a digital product in the European Union and led the development of a program that utilized tokenized data to connect multiple data sources. Additionally, she built global Market Access teams across North America, Europe, and Latin America, demonstrating her leadership in advancing healthcare access.